Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Talis Biomedical Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| SharesConverted for a 1-for-15 split | 732.2K | 740.9K | +8.65K (+1.2%) |
| Value | $5.27M | $4.27M | −$996.9K (−18.9%) |
New holders (4)
Institutions that held Talis Biomedical Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prelude Capital Management, LLC | 14,928 | $86.1K | 0.01% |
| Citigroup Inc | 5,267 | $30.3K | 0.00% |
| Qube Research & Technologies Ltd | 2 | $12 | 0.00% |
| JPMorgan Chase & Co | 1 | $6 | 0.00% |
Sold out (7)
Institutions that held Talis Biomedical Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 91,463 | $43.9K |
| Renaissance Technologies LLC | 54,900 | $26.0K |
| Two Sigma Securities, LLC | 49,007 | $23.5K |
| State Street Corp | 47,436 | $22.8K |
| Citadel Advisors LLC | 38,876 | $18.7K |
| Northern Trust Corp | 27,860 | $13.4K |
| Tudor Investment Corp Et Al | 10,000 | $4.80K |